Cancer Associated Thrombosis and Isoquercetin (CATIQ)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jeffrey Zwicker, MD
Beth Israel Deaconess Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Usc/norris Comprehensive Cancer Center
Los Angeles, California, United States
- Va Northern California Health Care System
Sacramento, California, United States
- Va Connecticut Healthcare System
West Haven, Connecticut, United States
- Veterans Affair Medical Center
Washington D.C., District of Columbia, United States
- York Hospital-Oncology Treatment Center
York Village, Maine, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Boston Va Healthcare System
Boston, Massachusetts, United States
- Mount Auburn Hospital
Waltham, Massachusetts, United States
- Washington University in St. Louis
St Louis, Missouri, United States
- Providence Va Medical Center
Providence, Rhode Island, United States
- White River Junction Va Medical Center
White River Junction, Vermont, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2015
- Primary completion
- 31 Dec 2018
- Completion
- 22 Oct 2019
- Last update posted
- 3 Mar 2021
- Registered enrollment
- 64
- Registry id
- NCT02195232
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.